Clough Capital Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-106,860
Closed -$12M 227
2023
Q3
$12M Buy
106,860
+41,390
+63% +$5.26M 1.29% 25
2023
Q2
$9.53M Buy
65,470
+9,200
+16% +$1.25M 0.96% 32
2023
Q1
$7.27M Sell
56,270
-44,530
-44% -$5.59M 0.78% 46
2022
Q4
$12.9M Buy
100,800
+82,340
+446% +$9.56M 1.3% 24
2022
Q3
$1.93M Sell
18,460
-300
-2% -$32.9K 0.21% 49
2022
Q2
$1.97M Sell
18,760
-75,320
-80% -$8.94M 0.24% 50
2022
Q1
$12M Buy
+94,080
New +$11.3M 0.91% 43
2021
Q4
Sell
-56,413
Closed -$8.02M 138
2021
Q3
$8.02M Sell
56,413
-63,417
-53% -$9.33M 0.49% 58
2021
Q2
$18.7M Buy
119,830
+104,622
+688% +$16.9M 1.02% 44
2021
Q1
$2.36M Sell
15,208
-597
-4% -$92.5K 0.11% 95
2020
Q4
$2.37M Buy
15,805
+3,646
+30% +$515K 0.17% 84
2020
Q3
$1.61M Hold
12,159
0.12% 85
2020
Q2
$1.41M Sell
12,159
-6,649
-35% -$766K 0.14% 96
2020
Q1
$1.85M Buy
+18,808
New +$2.47M 0.18% 69
2014
Q4
Sell
-125,866
Closed -$12.3M 212
2014
Q3
$12.3M Buy
+125,866
New +$12.4M 0.46% 74

Other funds holding ZBH

Clough Capital Partners's ZBH Position: Q4 2023 in Review

Clough Capital Partners sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 106,860 shares — an estimated $12M sold.

Clough Capital Partners first reported a position in ZBH in Q3 2014 and held it in 15 quarters. The position peaked at $18.7M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • Clough Capital Partners reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • Clough Capital Partners sold 106,860 Zimmer Biomet shares in Q4 2023, an estimated $12M.
  • Clough Capital Partners first reported a position in Zimmer Biomet in Q3 2014 and held it in 15 quarters.
  • Clough Capital Partners's Zimmer Biomet position peaked at $18.7M in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Clough Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.